News | February 11, 2026
Apollo Hospitals reports robust Q3 earnings; profit after tax humps to Rs. 3,835 million
Revenue from operations rose to Rs. 23,637 million for the three months ended December 31, 2025
Revenue from operations rose to Rs. 23,637 million for the three months ended December 31, 2025
Domestic sales increased 15.5%, supported by the relaunch of previously recalled products in the market
Rs. 40 cr buyback, 200% dividend announced
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
Operational leverage kicked in during the quarter, with adjusted EBITDA rising 21% year-on-year to Rs 147 crore
The Profit After Tax (PAT) for Q3 FY26 was Rs 49.68 crore, compared to Rs 46.78 crore in Q3 FY25
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
The revenues this quarter are in line with the outlook we envisaged for the year
On segmental performance, API revenues were largely stable at Rs. 454.3 crore for Q3 FY26, down 1% YoY
Subscribe To Our Newsletter & Stay Updated
